Gerresheimer reports lower half-year core profit

Gerresheimer reported lower core profit for the first half of 2026, pressured by weakness in its Moulded Glass unit and reduced demand for injection vials. The result signals softer end-market demand for the drug-packaging maker and is likely to weigh on company-specific earnings expectations.